Refractory Treatment Jobs: 3 Stellenangebote

3 Stellenangebote

$Stellenangebote Refractory Treatment Jobs gefunden bei Jobbörse Jobleads$

Stellenangebote Refractory Treatment Jobs bei Jobleads

Job vom 26.11.2024

Head of Quality Assurance (m/f/d)

• Martinsried, Bayern Führungs-/ Leitungspositionen Homeoffice möglich

MEHR

[...] effectively engaging their own immune systems to combat this malignant disease. We are now advancing to Phase 2b studies to confirm visugromab, our lead antibody, that has demonstrated durable anti- tumor efficacy with long- lasting objective responses in relapsed and refractory metastatic solid tumor patients in combination with anti- PD- 1 treatment. Our mission is to rapidly bring our next- generation immuno- oncology products to patients in need. Are you ready to [...]
Alle Quality Assurance Stellenangebote anzeigen

Job vom 07.11.2024

Clinical Specialist- Reducer

• Frankfurt, Hesse

MEHR

Shockwave Medical is a fast- growing medical device company focused on revolutionizing the treatment of advanced cardiovascular disease. With the recent acquisition of Neovasc and their innovative Reducer System, we are creating new opportunities for patients and physicians in the treatment of refractory angina long- lasting, debilitating chest pain that cannot be controlled by traditional medicine or surgical procedures and affects millions of [...]

Nichts verpassen: Jobs per eMail
Speichern Sie jetzt Ihre Jobsuche!

$Stellenangebote Refractory Treatment Jobs gefunden bei Jobbörse NewScientist Jobs$

Stellenangebote Refractory Treatment Jobs bei NewScientist Jobs

Job vor 3 Tagen gefunden The Christie NHS Foundation Trust

Clinical Research Fellow- Lymphoma

• Manchester, United Kingdom, Greater Manchester

MEHR

[...] team also actively contributes to the UK Lymphoma Research Group (formally NCRI) as sub- group chairs/ representatives and lead on a number of non- commercial trials. Examples include the ongoing international phase 3 RADAR trial, evaluating brentuximab vedotin as frontline treatment for early- stage Hodgkin lymphoma, and the randomised phase 2 REFRACT trial evaluating multiple novel therapies such as epcoritamab- lenalidomide [...] data from named- patient studies of brentuximab vedotin performed at the Christie were used in submissions to the European Medicines Agency resulting in provisional licensing of the drug that can now be used across the EU in patients with relapsed/ refractory CD30+ve lymphomas. Updated results of the same patient cohort were used in 2015 to support continued access to brentuximab vedotin [...]

Refractory Treatment Stellenangebote

3 Stellenangebote

Stellenangebote Refractory Treatment Jobs bei Jobleads

Head of Quality Assurance (m/f/d)

Clinical Specialist- Reducer

Stellenangebote Refractory Treatment Jobs bei NewScientist Jobs

Clinical Research Fellow- Lymphoma